Disease Markers · 2022 · 16 citations · 17 references
We speculate that BUB1, BUB1B, and BUB3 may be therapeutic targets for BrCa patients and also provide new therapeutic strategies for BrCa treatment.
17
Proteomic maps of breast cancer subtypes
Stefka Tyanova, Reidar Albrechtsen, Pauliina Kronqvist et al. · Nature Communications · 2016 · 315 citations · Full text
High expression of CDK1 and BUB1 predicts poor prognosis of pancreatic ductal adenocarcinoma
Junjie Piao, Lianhua Zhu, Jie Sun et al. · Gene · 2019 · 145 citations